11/2/22 08:55 | 11/1/22 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Schultz Kare | L3 | DO | P,CEO | M.d | 0 | 0.00 | 0 | 116 | 8 | 1,542 | D | | | | | | | | | | | | | | |
5/6/22 18:04 | 5/5/22 | IFF | International Flavors & Fragrances Inc | NY | Chem | OChm | Industrial Organic Chemicals | Schultz Kare | NY | D | | M.d | 0 | 0.00 | 0 | 1 | 427 | 1 | D | | | | | | | | | | | | | | |
3/8/22 16:12 | 3/4/22 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Schultz Kare | L3 | DO | P,CEO | M.dm | 0 | 0.00 | 0 | 294 | 26 | 1,426 | D | | | | | | | | | | | | | | |
3/2/22 07:51 | 2/28/22 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Schultz Kare | L3 | DO | P,CEO | M.d | 0 | 0.00 | 0 | 65 | 6 | 1,132 | D | | | | | | | | | | | | | | |
2/10/22 16:12 | 2/9/22 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Schultz Kare | L3 | DO | P,CEO | M.d | 0 | 0.00 | 0 | 27 | 3 | 1,067 | D | | | | | | | | | | | | | | |
11/3/21 07:25 | 11/1/21 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Schultz Kare | L3 | DO | P,CEO | M.d | 0 | 0.00 | 0 | 180 | 21 | 1,041 | D | | | | | | | | | | | | | | |
5/7/21 21:45 | 5/6/21 | IFF | International Flavors & Fragrances Inc | NY | Chem | OChm | Industrial Organic Chemicals | Schultz Kare | NY | D | | M.d | 0 | 0.00 | 0 | 0 | New | 0 | D | | | | | | | | | | | | | | |
3/8/21 16:12 | 3/4/21 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Schultz Kare | L3 | DO | P,CEO | M.d | 0 | 0.00 | 0 | 60 | 7 | 861 | D | | | | | | | | | | | | | | |
3/2/21 16:09 | 2/28/21 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Schultz Kare | L3 | DO | P,CEO | M.d | 0 | 0.00 | 0 | 65 | 9 | 801 | D | | | | | | | | | | | | | | |
2/11/21 16:11 | 2/9/21 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Schultz Kare | L3 | DO | P,CEO | M.d | 0 | 0.00 | 0 | 27 | 4 | 736 | D | | | | | | | | | | | | | | |
11/3/20 07:42 | 11/1/20 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Schultz Kare | L3 | DO | P,CEO | M.dm | 0 | 0.00 | 0 | 392 | 434 | 483 | D | | | | | | | | | | | | | | |
2/11/20 07:04 | 2/9/20 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Schultz Kare | L3 | DO | P,CEO | M.d | 0 | 0.00 | 0 | 27 | 42 | 90 | D | | | | | | | | | | | | | | |
11/5/19 07:19 | 11/3/19 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Schultz Kare | L3 | DO | P,CEO | M.d | 0 | 0.00 | 0 | 64 | New | 64 | D | | | | | | | | | | | | | | |